Opinion Review
Copyright ©The Author(s) 2020.
World J Clin Cases. Aug 6, 2020; 8(15): 3142-3155
Published online Aug 6, 2020. doi: 10.12998/wjcc.v8.i15.3142
Table 3 American Joint Committee on Cancer tumor node metastasis system for gastric and omental gastrointestinal stromal tumor
StageTNMMitotic rateStage description
IAT1 or T2; N0; M0Low (G1): mitotic rate 5/50 per HPF or lessT1: Tumor ≤ 2 cm; T2: Tumor > 2 cm but ≤ 5 cm; N0: no regional lymph node metastasis; M0: No distant metastasis
IBT3; N0; M0Low (G1)T3: Tumor > 5 cm but ≤ 10 cm; N0: no regional lymph node metastasis; M0: No distant metastasis
IIT1; N0; M0 or T2; N0; M0 or T4; N0; M0High (G2): mitotic rate > 5/50 HPF; High (G2); or Low (G1)T1: Tumor ≤ 2 cm; T2: Tumor > 2 cm but ≤ 5 cm; T4: Tumor > 10 cm in greatest dimension; N0: no regional lymph node metastasis; M0: No distant metastasis
IIIAT3; N0; M0High (G2)T3: Tumor > 5 cm but ≤ 10 cm; N0: no regional lymph node metastasis; M0: No distant metastasis
IIIBT4; N0; M0High (G2)T4: Tumor > 10 cm in greatest dimension; N0: no regional lymph node metastasis; M0: No distant metastasis
IVAny T; N1; M0 or Any T; Any N; M1Any rate or Any rateN1: Regional lymph node metastasis; M1: Distant metastasis